NCT00230217 · Interventional trial
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Overall registry status Completed
Phase 4
Conditions Hyperuricemia, Tumor Lysis Syndrome, Tumors
Delaware Valley sites
- University of Pennsylvania Health Systems · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory